PTJ
NVS icon

Paul Tudor Jones’s Novartis NVS Stock Holding History

Paul Tudor Jones’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-63,250
Closed -$9.48M – 4056
2026
Q1 		$9.66M Buy
63,250
+54,026
+586% +$8.28M 0.02% 760
2025
Q4 		$1.27M Sell
9,224
-25,776
-74% -$3.38M ﹤0.01% 2109
2025
Q3 		$4.49M Buy
+35,000
New +$4.27M 0.01% 1260
2024
Q2 		– Sell
-3,875
Closed -$375K – 2649
2024
Q1 		$375K Buy
+3,875
New +$397K ﹤0.01% 1772

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Paul Tudor Jones's NVS Position: Q2 2026 in Review

Paul Tudor Jones sold out of Novartis (NVS) in Q2 2026, closing a stake of 63,250 shares — an estimated $9.48M sold.

Paul Tudor Jones first reported a position in NVS in Q1 2024 and held it in 4 quarters. The position peaked at $9.66M in Q1 2026. 1,615 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Paul Tudor Jones reported no remaining Novartis position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 63,250 Novartis shares in Q2 2026, an estimated $9.48M.
  • Paul Tudor Jones first reported a position in Novartis in Q1 2024 and held it in 4 quarters.
  • Paul Tudor Jones's Novartis position peaked at $9.66M in Q1 2026.
  • 1,615 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.